Suppr超能文献

[肾病的纤维蛋白(原)裂解产物]

[Fibrin (ogen) Split products of nephropathies].

作者信息

Anger H

出版信息

Urologe A. 1975 Jan;14(1):20-4.

PMID:234643
Abstract

On healthy individuals fibrin(ogen) split products cannot be demonstrated in the blood. Catabolic products of fibrin and fibrinogen appear in the blood in case of general fibrinolysis, consumption coagulopathy with secondary fibrinolysis as well as local fibrin films with secondary fibrinolysis. The regular routine determination of fibrin(ogen) split products in serum or urine may indicate starting complications of many diseases. The appearance of these split products in case of renal affections indicates acute and active processes on the kidneys themselves; fibrin films appear in case of acute and chronic glomerulonephritis, casting-off crises on renal transplants, EPH gestosis, renal phlebothrombosis, hemolytic-uremic syndrom and occasionally urinary tract infections. The demonstration of fibrin(ogen) split products in serum or urine allows the following conclusions: a) acute and active process on the kidneys themselves; b) HMWS in urine indicate a fibrin film in the kidneys; c) an immediate beginning of an anticoagulation therapy; d) good possibilities to judge the therapeutic effect and by this the further progress of disease.

摘要

在健康个体中,血液中无法检测到纤维蛋白(原)降解产物。在全身性纤维蛋白溶解、继发性纤维蛋白溶解的消耗性凝血病以及继发性纤维蛋白溶解的局部纤维蛋白膜的情况下,纤维蛋白和纤维蛋白原的分解代谢产物会出现在血液中。血清或尿液中纤维蛋白(原)降解产物的常规测定可能提示多种疾病开始出现并发症。肾脏疾病时这些降解产物的出现表明肾脏本身存在急性和活跃的病变;急性和慢性肾小球肾炎、肾移植排斥危机、妊娠高血压综合征、肾静脉血栓形成、溶血尿毒综合征以及偶尔的尿路感染时会出现纤维蛋白膜。血清或尿液中纤维蛋白(原)降解产物的检测可得出以下结论:a)肾脏本身存在急性和活跃的病变;b)尿液中的高分子量物质表明肾脏存在纤维蛋白膜;c)立即开始抗凝治疗;d)有很好的可能性判断治疗效果以及疾病的进一步进展情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验